Pharmacologic treatments for covid-19 patients
Combined metabolic cofactor supplementation vs Placebo
This comparison will not be updated. Last search date 22 Oct, 2021.
Outpatients
Forest plots
(last update: 2021-07-08)
Hospitalized patients
Forest plots
(last update: 2022-04-29)
To access all information :
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=102
Back to your research
| Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
|---|---|---|---|---|---|---|---|---|
| Treatment 1 | Treatment 2 | |||||||
| NCT04573153 Altay O, Adv. Sci., 2021 Full text Full text Commentary |
Mixed |
Combined metabolic cofactor supplementation |
Placebo |
RCT | Outpatients with confirmed COVID-19 (mild) treated at a single center in Turkey | N=93 |
Some concerns Details |
|